by Richard Jefferys In the earliest days after the discovery of HIV in the mid-1980s, uncertainty reigned regarding how the immune system responded to the virus. Initially, it was thought that the time between HIV infection and the development of…
TAG at 20: Early Campaigns; The Odyssey of Therapeutic Vaccines for HIV; What You Don’t Know, You Can Sell; Does Obama’s 2013 Budget Herald the End of PEPFAR?; Childhood TB Advocacy Picks Up Steam
Reforming NIH AIDS Research, Boosting the Budget, and Revitalizing the Basic Science of HIV Infection by Mark Harrington On January 22, 2012, the Treatment Action Group marked its twentieth anniversary. Over the past two decades, we have helped to accelerate…
As representatives of organizations that advocate for an evidence-based and robust response to global AIDS, we respond to your fiscal year 2013 budget request for the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)—the flagship bilateral AIDS program—with shock and dismay.
Treatment Action Group (TAG) is deeply disappointed by President Obama’s proposed cuts to PEPFAR (President’s Emergency Plan for AIDS Relief) and bilateral TB funds, freezing of NIH (National Institutes of Health) research as well as the insufficient attention to the worsening domestic AIDS crisis in the administration's fiscal year 2013 budget plan.
By Richard Jefferys February 2012 - Inaugurated in 2003, the bi-annual International Workshop on HIV Persistence during Therapy (aka “the persistence workshop”) is the brainchild of researcher Alain Lafeuillade. The meeting presaged the recent explosion of interest in pursuing a…
Broad, Brilliantly Coordinated Offensive Brings Sneaky Concession From Illinois' Rep. Porter Threats 'Far From Over' When the Republicans took charge of Congress in 1994 and liberal stalwarts like Ann Richards of Texas and Mario Cuomo of New York went down…
A Look Back at an Extraordinary Year for Basic and Clinical Research on AIDS -- and the Questions Raised Additional Surprises Expected The year 1996 witnessed seismic developments in AIDS research. On many fronts -- the basic and the clinical,…
Effect of ddI on Ganciclovir May Explain Disparity Between Two Prophylaxis Studies And CMV PCR Makes its Debut Readers of TAGline are asked to harken back to the duelling ganciclovir studies unveiled this past winter (see the March TAGline, vol…
Flurry of Discoveries in Multiple Labs Leads to Identification of HIV's Second Receptor -- And New Therapeutic Target The Good, the Bad, the Ugly For nearly a decade Jay Levy, the crotchety virologist at the University of California in San…